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Abstract
The treatments of bone loss have been extended to the molecular level and previous research has found that
vascular endothelia growth factor (VEGF) can enhance the vascular network building around bone injury to aid
healing progress. In this manuscript, we discussed the effects of VEGF on bone cells’ metabolism and activity.
VEGF could enhance osteogenesis by inducing neovascularization and direct effects on bone cells via regulation on
genes osteoprotegerin (OPG)/the receptor activator of nuclear factor kappa beta ligand (RANKL), alkaline
phosphatase (ALP), osteopontin (OPN) and osteocalcin (OCN), without causing abnormal cell metabolism, which
may shed lights on new clinical treatments of bone loss.
Keywords Vascular endothelia growth factor; Bone remodeling; Cell
metabolism
Introduction
Bone loss, caused by diseases, traumas and surgical procedures, is a
problem resulting in dental or craniofacial defects and even leading to
ever-increasing social impacts. Traditional approaches of the bone
repair and regeneration include distraction osteogenesis, orthognathic
surgery, bone grafting, et al., which were limited by bone graft
resorption, donor site morbidity, antigenicity potential and disease
transmission [1]. Hence, there is an urgent need to explore new
improvement in bone induction and regeneration [2].
Blood supply is the essential factor of bone regeneration.
Angiogenesis, the ingrowth of new capillary blood vessels, is a critical
component of skeletal development, which is closely correlated to the
success of bone regeneration [3,4]. Hence, a growth factor which can
enhance both angiogenesis and osteogenesis is ideal for the search as
the addition of such a factor may be a method to improve the
outcomes of bone formation [5].
Vascular endothelia growth factor (VEGF), a key regulator of
angiogenesis and osteogenesis during bone regeneration, has been
found to be highly expressed in vascularized tissues [6]. Neonatal mice
with conditional knockouts of VEGF in the growth plates had great
problems in bone formation, which confirmed the role of VEGF in
bone development [7].
In addition to enhancing bone formation by increasing
vascularization, Does VEGF have direct effect on bone cells which
contributes to osteogenesis? In this manuscript, we would like to
review and discuss the roles of VEGF involved in the following aspects:
initial removal of ‘old’ bone; bone formation; dynamic balance of bone
remodeling; and effects on cell metabolism.
Initial Removal of Old Bone
The initial step of bone remodeling is removal of ‘old’ bone to
provide places for new bone formation [8]. Osteoblasts play an
essential role in osteogenesis, and are also responsible for
differentiation and maturation of osteoclasts [9,10]. It was clear that
osteoprotegerin (OPG) and the receptor activator of nuclear factor
kappa beta ligand (RANKL) are two important regulatory factors in
bone resoprtion, which can be expressed by osteoblasts, and also
involve in regulating activation and function of osteoclasts [11,12].
In order to investigate the effects of VEGF on bone remodeling,
MC3T3-E1, one of the mouse osteoblast precursor cell lines, was
incubated with VEGF [8]. Cells were collected at different time points
(24,48 and 72 hrs) respectively and total RNA was isolated
immediately. Real-time polymerase chain reaction (qPCR) was carried
out to quantify the mRNA expression of OPG and RANKL [8].
24 hrs 48 hrs 72 hrs
OPG ↓*** NS ↑***
RANKL NS NS NS
OPG/RANKL ↓*** NS ↑***
*** ( p<0.001); NS (Not Significant)
Table 1: Effects of VEGF on expression of OPG and RANKL in
MC3T3-E1 bone cells [8]
In this study [8], it was shown that after VEGF induction, the
mRNA expression of OPG significantly dropped 7% compared to
control at the time point of 24 hrs (p<0.001), while showed no
difference from control at 48 hr (p>0.05). But at 72 hrs, OPG increased
dramatically by 133% compared to control (p<0.001) [8]. There was
no difference in the expression of RANKL between test and control
groups at any time point. Thus the ratio OPG/RANKL declined at first
and then rose later [8]. The data was summarized in Table 1.
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There are several important steps in bone resorption: recruitment of
osteoclasts, differentiation of osteoclasts, dissolution of bone minerals,
and degradation of organic matrix [12]. Osteoblasts express RANKL as
a membrane associated factor, and osteoclast precursors express
RANK, a receptor for RANKL [13]. By direct cell-to-cell contact,
osteoclast precursors recognize RANKL and differentiate into
osteoclasts. Therefore, osteoblasts play an essential role in osteoclasts
differentiation. OPG, a decoy receptor for RANKL secreted by
osteoblasts, can suppress the links between RANKL and RANK and
further block their functions in osteoclastogenesis and bone resorption
[14]. The balanced expression ratio of OPG/RANKL was suggested to
be crucial for bone remodeling [15].
It was shown in Table 1 that the mRNA expression of OPG
decreased significantly while RANKL kept unchanged at the beginning
(24 hrs), leading to the decrease of OPG/RANKL expression ratio in
MC3T3-E1 at the early phase by VEGF induction. The reduced OPG/
RANKL ratio suggests bone resorption was enhanced, conducive to
the removal the ‘old’ bone as an essential trigger of bone remodeling.
These findings indicated that VEGF may promote bone resoprtion at
the early time of bone remodeling, neovascularization and
revitalization of the dead bone.
Bone Formation
Following the removal of ‘old’ bone, osteoblasts differentiated from
osteoprogenitor cells arise at resorption site and participate in bone
formation [9]. MC3T3-E1 which comes from osteoblast precursor cell
line can differentiate along the osteoblast pathway [16]. In order to
investigate the effect of VEGF mediating bone formation, using the
same in vitro model of MC3T3-E1 cell cultured with VEGF [8],
Alkaline phosphatase (ALP), osteopontin (OPN) and osteocalcin
(OCN) were chosen as the markers [8], all of which are common bone
formation factors [17,18]. ALP is known to be responsible for
osteoblastic differentiation [17]. OPN is a major non-collagenous bone
matrix protein secreted into the mineralizing extracellular matrix by
osteoblasts during bone development [18]. OCN is closely related to
calcification [19].
24 hrs 48 hrs 72 hrs
ALP ↑*** ↓*** ↓*
OPN ↓*** NS ↑***
OCN ↓*** NS ↑***
* (p<0.05); *** (p<0.001); NS (Not Significant)
Table 2: Effects of VEGF on expression of ALP, OPN and OCN in
MC3T3-E1 bone cells [8,20]
It was found that the mRNA expression of ALP increased by 73%
after VEGF incubation for 24 hrs (p<0.001), but reduced by 14% and
41% at 48 hrs (p<0.001) and 72 hrs (p<0.05) respectively when
compared to the control [8]. For the other two factors, OPN
expression decreased by 11% (p<0.001) and OCN dropped by 41%
(p<0.001) at 24 hrs; both the expression of OPN and OCN did not
show any change at 48 hrs; but at 72hrs, OPN increased by 94%
(p<0.001) and OCN grew by 149% (p<0.001) [8,20]. The data was
summarized in Table 2. The dramatic upregulation of the three bone
formation related markers at different time indicate the enhancement
of bone formation by VEGF, and the time-related change is coincide
with three markers’ chronological function in osteogenesis progress.
Dynamic Balance of Bone Remodeling
Bone remodeling, the two sub-processes bone formation and
resorption, is a lifelong dynamic balance process, determined by the
function of osteoblasts and osteoclasts, and precisely mediated by
various cytokines during development and maintenance of the
skeleton [21]. Any dysregulation in development of osteoclast and
osteoblast or the disruption of the balance between the sub-processes
will result in bone diseases. For the roles of VEGF on bone cells, we
would like to highlight two aspects of the dynamic balance.
For bone resorption, OPG/RANKL ratio degreased at early phase
(24 hr) in MC3T3-E1 by VEGF induction, indicating more bone
resorption for removal of old bones in initial phase [8]. However, at
later phase (72 hrs), the increased OPG/RANKL ratio showed that
bone resorption was suppressed at the later stage of bone remodeling
[8].
For bone formation, ALP, OPN and OCN were found increasing at
different phases of intervention [8,20]. The process of osteogenesis
consists of cell proliferation, cell differentiation, and mineralization,
and ALP, OPN and OCN are related to the different stages of this
process: ALP is an early marker, which is known to be responsible for
osteoblastic differentiation; while OPN and OCN are regarded as late
markers, as OPN is a major non-collagenous bone matrix protein
secreted into the mineralizing extracellular matrix, and OCN is also
closely related to calcification [17-19]. It was shown that the increase
of ALP happened at the early stage (24 hrs) [8], while OPN and OCN
had a significant increase at late stage (72 hrs) [8,20], consistent with
the different time-serial function of ALP, OPN and OCN, indicating
that VEGF play different regulation roles in different bone formation
stages.
Effects on Cell Metabolism
Growth factors, like VEGF, a group of special polypeptides that
stimulate cell proliferation, are major growth-regulatory molecules for
cells in culture and probably in vivo [22]. So the excitement and
attention of growth factors focus on not only the regulation of normal
cell growth but also the involvement of growth factor-initiated
pathways causing abnormal cell metabolism and even in the etiology
of cancer [22].
Nicotinamide adenine dinucleotide (NADH), which can emit
strong fluorescence, has been used to probe cell activity for many years
[23], as the ratio of free/enzyme-bound NADH differentiated by their
fluorescence decay is a good indicator of the cell metabolic state
[24,25]. Tryptophan is one kind of amino acids acting as building
blocks in protein, the fluorescence intensity of which can convey the
information about protein content, protein structure, and changes in
the cellular microenvironment [26].
We have built a time-resolved two-photon excitation fluorescence
microscopy and spectroscopy system equipped with a multichannel
time-correlated single-photon-counting facility [27]. This system
provides a unique approach to measure fluorescence signals of NADH
and tryptophan in different cellular organelles and the cytoplasm.
Importantly, the system detects fluorescence signals in living cells
without killing them, thereby permitting real-time observations of
cellular endogenous fluorescence with different intervention [28,29].
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To investigate the effect of VEGF on bone cells’ metabolism,
MC3T3-E1 was cultured with VEGF. The endogenous fluorescence of
NADH and tryptophan was measured at different culture time points
(24,48 and 72 hrs) with the two-photon autofuorescence microscopy
which can measure three types of characteristics of the
autofluorescence, i.e. the intensity distribution in 2D area named
fluorescence image; the fluorescence spectra; and the fluorescence
lifetime. In the measurement of both NADH and tryptophan
fluorescence (Figure 1), regarding the three characteristics, there was
no difference between the VEGF treated and control cells. It was
suggested that application of the growth factor VEGF does not cause
abnormal cell metabolism.
Figure 1: Fluorescence image and spectra. A, NADH fluorescence
image and spectra of control cells (72 hrs); B, NADH fluorescence
image and spectra of VEGF treated cells (72 hrs); C, Tryptophan
fluorescence image and spectra of control cells (72 hrs); D,
Tryptophan fluorescence image and spectra of VEGF treated cells
(72 hrs). There were no difference between the VEGF treated and
control cells, which suggested that application of the growth factor
of VEGF does not cause the abnormal cell metabolism
Figure 2: Effects of VEGF on bone remodeling
In conclusion, VEGF could play an important role in osteogenesis
enhancement by inducing neovascularization and direct effects on
bone cells via regulation on genes ALP, OPN, OCN and OPG/RANKL
(Figure 2) without causing abnormal cell metabolism. The pivotal role
of VEGF in bone remodeling and healing may shed lights on the new
clinical treatment of bone loss.
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